
Better Therapy Selection for Childhood Leukemia
Despite decades of optimization of treatment protocols, the prognosis for acute myeloid leukemia in children (pediatric AML, pedAML) remains poor for many patients. A research team from CeMM, St. Anna Children’s Cancer Research Institute (CCRI), the Medical University of Vienna, and St. Anna Children’s Hospital has now succeeded in developing a method for the early detection of resistance mechanisms in pediatric AML, using cutting-edge imaging,…

From Basic Research to Biotech Innovation: Five Years of Proxygen and Solgate
In 2020, two biotech startups with roots at CeMM set out to turn academic discoveries into innovative drug discovery platforms. Five years later, Proxygen and Solgate have established themselves as promising players in the biotech landscape. In this joint interview of Bernd Boidol (Proxygen) and Ariel Bensimon (Solgate), the co-founders reflect on their journeys, challenges, and the crucial role of basic research. Looking back at your founding…

Aging studied at multiple scales: CeMM PI André Rendeiro awarded ERC Starting Grant
CeMM Principal Investigator André Rendeiro has been awarded a prestigious Starting Grant by the European Research Council (ERC). His project will combine large-scale human tissue imaging with advanced computational methods to unravel how aging manifests across different anatomical scales – from cells and tissues to organs – and how these changes contribute to the onset of age-associated diseases. Aging is one of the most fundamental biological…

European alliance to advance proximity-induced drug modalities
In a now published Perspective in Molecular Cell (DOI: 10.1016/j.molcel.2025.07.018), scientists from six leading European research institutions, Goethe University Frankfurt, IRB Barcelona, CeMM and AITHYRA in Vienna, the University of Dundee, and EPFL Lausanne, propose the creation of a European Alliance to accelerate the development of proximity-induced drug modalities. These therapeutic approaches aim to harness the concept of bringing…

Kaan Boztug Receives Novartis Prize for Therapy-Relevant Immunological Research
As a pediatrician and expert in rare diseases of the immune system and blood formation, CeMM Adjunct PI Kaan Boztug bridges clinical practice and research in his work. This approach enables him to translate molecular insights directly into the care of young patient. A strategy that lends his scientific breakthroughs exceptional clinical relevance. Boztug’s field of expertise is the study of inborn errors of immunity (IEI) and the elucidation of…

How Immune Cells Switch into Attack Mode – New Insights into Macrophage Biology
Fighting off pathogens is a tour de force that must happen with speed and precision. A team of researchers at CeMM and MedUni Vienna led by Christoph Bock and Matthias Farlik has investigated how macrophages—immune cells that are the body’s first responders—master this challenge. Their study, published in Cell Systems (DOI: 10.1016/j.cels.2025.101346), offers a time-resolved analysis of the molecular processes that unfold when these cells…

Christoph Bock elected as EMBO Member
We are delighted to announce that Christoph Bock, Principal Investigator at CeMM, has been elected as a Member of the European Molecular Biology Organization (EMBO). With this prestigious recognition, EMBO honors Christoph Bock for his scientific contributions at the interface of biotechnology, bioinformatics, and molecular medicine. His research combines experimental immunology and cancer biology with computational methods, including machine…

How a Faulty Transport Protein in the Brain Can Trigger Severe Epilepsy
Citrate is essential for the metabolism and development of neurons. A membrane transport protein called SLC13A5 plays a central role in this process and has previously been linked to a particularly severe form of epileptic encephalopathy. Building on data from the recently completed RESOLUTE and REsolution flagship projects, scientists at CeMM have comprehensively studied the function and structure of the membrane transporter SLC13A5,…

CeMM PI Laura de Rooij awarded TRANSCAN-3 grant for cancer research project
Congratulations to CeMM Principal Investigator Laura de Rooij on being awarded a prestigious grant as coordinator of the new Europe-wide project HAVOC — one of just 15 consortia selected under the Transcan-3 Joint Transnational Call 2024! Cancer remains the second leading cause of death globally, with more than 3.9 million new cases and 1.9 million deaths each year. Through this initiative, the TRANSCAN-3 network is investing €16.7 million to…

Deciphering Cellular Logistics: A First Blueprint of Chemical Transport Pathways
An unprecedented international effort to decode how cells manage the transport of chemical substances has culminated in four groundbreaking studies published in Molecular Systems Biology. Led by Giulio Superti-Furga at CeMM and supported by an international consortium of academic and pharmaceutical partners under the European Union's Innovative Medicines Initiative, this decade-long project provides the first comprehensive functional blueprint of…

18th Landsteiner Lecture with Tony Wyss-Coray
How embarrassing it can be to forget someone’s name during a social event! With this relatable anecdote, Tony Wyss-Coray, Professor of Neurology and Neurological Sciences at Stanford Medicine, opened the 18th Landsteiner Lecture on May 12, 2025. His talk, titled “Young Blood for Old Brains and the Quest to Slow Aging”, immediately captivated the audience. Wyss-Coray used the story to illustrate a universal truth: our brains inevitably decline…

Skin infections can increase allergic inflammation in the lungs
A temporary bacterial infection of the skin can cause long-lasting changes in the immune system and increase allergic inflammation. This is the result of a study led by CeMM and the Medical University of Vienna, recently published in the prestigious journal Science Immunology. The findings uncover a previously unknown connection between the skin, bone marrow and lungs, offering new prospects for the development of treatment strategies for…

New therapeutic approach for pulmonary fibrosis
Pulmonary fibrosis is a severe and chronic lung disease that predominantly affects older adults. With no specific treatments currently available, lung transplantation often remains the only option to extend patients’ lives. A research team from CeMM and MedUni Vienna has now uncovered that the aging immune system plays a crucial role in the onset and progression of the disease. Their study, published in the leading journal Science Immunology,…

14th CeMM S.M.A.R.T. Lecture with Walter Pohl
Who are we? Where do we come from? Where do we belong? And where are we going? Walter Pohl started the 14th S.M.A.R.T. Lecture held on 26 March at CeMM with these fundamental questions of historical research, emphasizing why history remains of utmost importance to modern societies, beyond popular preconceptions. In his engaging lecture, he demonstrated how these questions can be approached through a fascinating combination of classical…

CeMM Research Report 2024: Equations for Life
We are delighted to present the CeMM Research Report 2024, centered around “Equations for Life”! Behind every biological process and every measurement in the life sciences lies a mathematical equation. These equations help us describe, analyze, and predict—from atomic interactions to complex ecological systems. The cover of this report is the result of a unique team effort: During a CeMM outing in October 2024, our community came together to…